Acute	acute	O	B_disease
liver	liver	O	B_disease
failure	failure	O	I_disease
with	with	O	O
concurrent	concurrent	O	O
bupropion	bupropion	S_chemical	O
and	and	O	O
carbimazole	carbimazole	S_chemical	O
therapy	therapy	O	O
.	.	O	O

OBJECTIVE	objective	O	O
:	:	O	O
To	to	O	O
report	report	O	O
a	a	O	O
case	case	O	O
of	of	O	O
fatal	fatal	O	O
liver	liver	O	B_disease
failure	failure	O	I_disease
possibly	possibly	O	O
associated	associated	O	O
with	with	O	O
concurrent	concurrent	O	O
use	use	O	O
of	of	O	O
bupropion	bupropion	S_chemical	O
and	and	O	O
carbimazole	carbimazole	S_chemical	O
.	.	O	O

CASE	case	O	O
SUMMARY	summary	O	O
:	:	O	O
A	a	O	O
41-year-old	41-year-old	O	O
Chinese	chinese	O	O
man	man	O	O
with	with	O	O
a	a	O	O
history	history	O	O
of	of	O	O
hyperthyroidism	hyperthyroidism	O	S_disease
had	had	O	O
been	been	O	O
treated	treated	O	O
with	with	O	O
carbimazole	carbimazole	S_chemical	O
and	and	O	O
propranolol	propranolol	S_chemical	O
for	for	O	O
the	the	O	O
past	past	O	O
5	5	O	O
years	years	O	O
.	.	O	O

He	he	O	O
received	received	O	O
a	a	O	O
10-day	10-day	O	O
course	course	O	O
of	of	O	O
bupropion	bupropion	S_chemical	O
as	as	O	O
an	an	O	O
aid	aid	O	O
for	for	O	O
smoking	smoking	S_chemical	O
cessation	cessation	O	O
10	10	O	O
weeks	weeks	O	O
prior	prior	O	O
to	to	O	O
presentation	presentation	O	O
.	.	O	O

He	he	O	O
developed	developed	O	O
acute	acute	O	B_disease
liver	liver	O	B_disease
failure	failure	O	I_disease
with	with	O	O
rapid	rapid	O	O
deterioration	deterioration	O	O
of	of	O	O
renal	renal	O	O
function	function	O	O
.	.	O	O

Liver	liver	O	O
biopsy	biopsy	O	O
showed	showed	O	O
evidence	evidence	O	O
of	of	O	O
nonspecific	nonspecific	O	O
drug-induced	drug-induced	O	O
acute	acute	O	O
liver	liver	O	B_disease
injury	injury	O	I_disease
.	.	O	O

His	his	O	O
condition	condition	O	O
was	was	O	O
further	further	O	O
complicated	complicated	O	O
by	by	O	O
sepsis	sepsis	O	S_disease
and	and	O	O
coagulopathy	coagulopathy	O	S_disease
.	.	O	O

Death	death	O	S_disease
resulted	resulted	O	O
19	19	O	O
days	days	O	O
after	after	O	O
the	the	O	O
onset	onset	O	O
of	of	O	O
symptoms	symptoms	O	O
.	.	O	O

The	the	O	O
likelihood	likelihood	O	O
that	that	O	O
bupropion	bupropion	S_chemical	O
induced	induced	O	O
hepatotoxicity	hepatotoxicity	O	S_disease
in	in	O	O
our	our	O	O
patient	patient	O	O
was	was	O	O
possible	possible	O	O
,	,	O	O
based	based	O	O
on	on	O	O
the	the	O	O
Naranjo	naranjo	O	O
probability	probability	O	O
scale	scale	O	O
.	.	O	O

DISCUSSION	discussion	O	O
:	:	O	O
Although	although	O	O
there	there	O	O
is	is	O	O
increasing	increasing	O	O
evidence	evidence	O	O
of	of	O	O
hepatotoxicity	hepatotoxicity	O	S_disease
induced	induced	O	O
by	by	O	O
bupropion	bupropion	S_chemical	O
,	,	O	O
this	this	O	O
is	is	O	O
the	the	O	O
first	first	O	O
case	case	O	O
of	of	O	O
fatality	fatality	O	O
that	that	O	O
could	could	O	O
have	have	O	O
resulted	resulted	O	O
from	from	O	O
acute	acute	O	B_disease
liver	liver	O	B_disease
failure	failure	O	I_disease
in	in	O	O
a	a	O	O
patient	patient	O	O
receiving	receiving	O	O
bupropion	bupropion	S_chemical	O
while	while	O	O
on	on	O	O
concomitant	concomitant	O	O
treatment	treatment	O	O
with	with	O	O
carbimazole	carbimazole	S_chemical	O
.	.	O	O

CONCLUSIONS	conclusions	O	O
:	:	O	O
Clinicians	clinicians	O	O
should	should	O	O
be	be	O	O
aware	aware	O	O
of	of	O	O
the	the	O	O
possibility	possibility	O	O
of	of	O	O
acute	acute	O	O
liver	liver	O	O
insult	insult	O	O
induced	induced	O	O
by	by	O	O
bupropion	bupropion	S_chemical	O
given	given	O	O
concurrently	concurrently	O	O
with	with	O	O
other	other	O	O
hepatotoxic	hepatotoxic	O	S_disease
drugs	drugs	O	O
.	.	O	O

